NCT01647620 - A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Deep Vein Thrombosis LegStroke (in Patients With Atrial Fibrillation)

Interventions

DRUG

DPOC-4088

A 10-day oral dosing of DPOC-4088 prolonged release tablet (20 hr release formulation). Starting dose in dose step 1 is 100 mg daily.

DRUG

Placebo

A 10-day oral dosing of matching placebo prolonged release tablet.

Trial Locations (1)

Drug Research Unit Ghent, Ghent